Human peritoneal mesothelial cells (HMC) contribute to the activation and control of inflammatory processes in the peritoneum by their potential to produce various inflammatory mediators. The present study was designed to assess the effect of glucose, the osmotic active compound in most commercially available peritoneal dialysis fluids, on the synthesis of the C-C chemokine monocyte chemoattractant protein-1 (MCP-1) in cultured HMC. The MCP-1 concentration in the cell supernatants was determined by enzyme-linked immunosorbent assay and the MCP-1 mRNA expression was examined using Northern blot analysis. Incubation of HMC with glucose (30–120 mM) resulted in a time- and concentration-dependent increase in MCP-1 protein secretion and mRNA expression. After 24 h the MCP-1 synthesis was increased from 2.8 ± 0.46 to 4.2 ± 0.32 ng/105 cells (n = 5, p < 0.05) in HMC treated with 60 mM glucose. In contrast, osmotic control media containing either the metabolically inert monosaccharide mannitol or NaCl did not influence MCP-1 production. The stimulating effect of high glucose on MCP-1 expression in HMC was mimicked by activation of protein kinase C (PKC) with the phorbol ester PMA (20 nM). Coincubation of the cells with glucose and the specific PKC inhibitor Ro 31–8220 completely blunted glucose-mediated MCP-1 expression. In summary, our results indicate that glucose induces MCP-1 synthesis by a PKC-dependent pathway. Since osmotic control media did not increase MCP-1 release, it is suggested that the effect of glucose is mainly related to metabolism and not to hyperosmolarity. These data may in part explain elevated steady-state levels of MCP-1 found in the dialysis effluent of continuous ambulatory peritoneal dialysis patients.

Keywords:
Mesothelial cells, Glucose, Monocyte chemoattractant protein-1, Peritoneal dialysis
1.
Topley N, Williams JD: Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int Suppl 1994;48:71–78.
2.
Jonjic N, Peri G, Bernasconi S, Sciacca FL, Colotta F, Pelicci P, Lanfrancone L, Mantovani A: Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992;176:1165–1174.
3.
Cannistra SA, Ottensmeier C, Tidy J, De Franzo B: Vascular cell adhesion molecule-1 expressed by peritoneal mesothelium partly mediates the binding of activated human T lymphocytes. Exp Hematol 1994;22:996–1002.
4.
Topley N, Brown Z, Jorres A, Westwick J, Davies M, Coles GA, Williams JD: Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1-beta and tumor necrosis factor-alpha. Am J Pathol 1993;142:1876–1886.
5.
Douvdevani A, Rapoport J, Konforty A, Argov S, Ovnat A, Chaimovitz C: Human peritoneal mesothelial cells synthesize IL-1-alpha and -beta. Kidney Int 1994;46:993–1001.
6.
Antony VB, Hott JW, Kunkel SL, Godbey SW, Burdick MD, Strieter RM: Pleural mesothelial cell expression of C-C (monocyte chemotactic peptide) and C-X-C (interleukin-8) chemokines. Am Respir Cell Mol Biol 1995;12:581–588.
7.
Visser CE, Tekstra J, Brouwer-Steenbergen JJ, Tuk CW, Boorsma DM, Sampat-Sardjoepersad SC, Meijer S, Krediet RT, Beelen RH: Chemokines produced by mesothelial cells: huGRO-alpha, IP-10, MCP-1 and RANTES. Clin Exp Immunol 1998;112:270–275.
8.
Goodman RB, Wood RG, Martin TR, Hanson-Painton O, Kinasewitz GT: Cytokine-stimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP-1/IL-8. J Immunol 1992;148:457–465.
9.
Banas B, Sitter T, Fischereder M, Banas B, Luckow B, Schlöndorff D: Human peritoneal mesothelial cells express receptors for CC chemokines, CXC chemokines and fractalkine. J Am Soc Nephrol 1999;10:A2562:507 A.
10.
Schlondorff D, Nelson PJ, Luckow B, Banas B: Chemokines and renal disease. Kidney Int 1997;51:610–621.
11.
Tekstra J, Visser CE, Tuk CW, Brouwer Steenbergen JJ, Burger CW, Krediet RT, Beelen RH: Identification of the major chemokines that regulate cell influxes in peritoneal dialysis patients. J Am Soc Nephrol 1996;7:2379–2384.
12.
Ajuebor MN, Flower RJ, Hannon R, Christie M, Bowers K, Verity A, Perretti M: Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model. J Leukoc Biol 1998;63:108–116.
13.
Robson RL, Witowski J, Loetscher P, Williams JD, Topley N: Control of leukocyte migration across the mesothelium by IFN involves differential regulation of C-C and C-X-C chemokine production. Perit Dial Int 1998;18:118.
14.
Sach M, Loetscher P, Burger JA, Knopf HP, Schollmeyer P, Dobos GJ: MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages. Adv Perit Dial 1995;11:19–23.
15.
Sach M, Bauermeister K, Burger JA, Loetscher P, Elsner J, Schollmeyer P, Dobos GJ: Inverse MCP-1/IL-8 ratio in effluents of CAPD patients with peritonitis and in isolated cultured human peritoneal macrophages. Nephrol Dial Transplant 1997;12:315–320.
16.
Bos HJ, Struijk DG, Tuk CW, de Veld JC, Helmerhorst TJ, Hoefsmit EC, Arisz L, Beelen RH: Peritoneal dialysis induces a local sterile inflammatory state and the mesothelial cells in the effluent are related to the bacterial peritonitis incidence (letter). Nephron 1991;59:508–509.
17.
Breborowicz A, Oreopoulos DG: Biocompatibility of peritoneal dialysis solutions. Am J Kidney Dis 1996;27:738–743.
18.
Sitter T, Haslinger B, Mandl S, Fricke H, Held E, Sellmayer A: High glucose increase prostaglandin E2 synthesis in human peritoneal mesothelial cells: Role of hyperosmolarity. J Am Soc Nephrol 1998;9:2005–2012.
19.
Sitter T, Mandl-Weber S, Wörnle M, Haslinger B, Goedde M, Kooistra T: D-Glucose increases the synthesis of tissue-type plasminogen activator in human peritoneal mesothelial cells. Thromb Haemost 1999;82:1171–1177.
20.
Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD, Wadsworth J, Westmacott D, Wilkinson SE: Potent selective inhibitors of protein kinase C. FEBS Lett 1989;259:61–63.
21.
Van Hinsbergh VW, Kooistra T, Scheffer MA, Hajo van Bockel J, van Muijen GN: Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990;75:1490–1497.
22.
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156–159.
23.
Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 1991;261:F571-F577.
24.
Ihm CG, Park JK, Hong SP, Lee TW, Cho BS, Kim MJ, Cha DR, Ha H: A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells. Nephron 1998;79:33–37.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.